B-cell-specific Moloney murine leukemia virus integration site 1 messenger RNA (BMI-1 mRNA) (BMI-1 mRNA)

B-cell-specific Moloney murine leukemia virus integration site 1 (BMI-1) mRNA encodes a critical protein component of the Polycomb Repressive Complex 1 (PRC1), which functions as an epigenetic silencer (UniProt). BMI-1 is essential for maintaining the self-renewal capacity of both normal and cancer stem cells by repressing the CDKN2A locus, which encodes the tumor suppressors p16INK4a and p14ARF (PubMed, PMID: 12730594). Overexpression of BMI-1 is observed in a wide range of malignancies, including leukemia and various solid tumors, where it promotes cell proliferation, epithelial-mesenchymal transition, and resistance to chemotherapy (NCBI Gene). Targeting BMI-1 at the mRNA level, through small molecules like PTC596 or RNA-interference technologies, aims to deplete the protein pool and restore tumor suppressor pathways (ClinicalTrials.gov). This therapeutic strategy is particularly focused on eradicating cancer stem cells that are often responsible for disease recurrence and metastasis. However, because BMI-1 is also vital for normal stem cell maintenance, careful monitoring of hematological and neurological safety is required during clinical development (PubMed, PMID: 27535395).

Other names

BMI1 mRNAPolycomb group RING finger protein 4 mRNAPCGF4 mRNARNF51 mRNA

Small molecule-mediated reduction of BMI-1 protein levels through modulation of mRNA translation or stability, or direct mRNA degradation via RNA interference.